Overall market sentiment has been down on Cyclo Therapeutics Inc (CYTH) stock lately. CYTH receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.
Cyclo Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CYTH!
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With CYTH Stock Today?
Cyclo Therapeutics Inc (CYTH) stock is trading at $1.50 as of 1:13 PM on Thursday, Sep 21, a decline of -$0.10, or -6.25% from the previous closing price of $1.60. The stock has traded between $1.42 and $1.61 so far today. Volume today is more active than usual. So far 76,920 shares have traded compared to average volume of 37,966 shares.
To see InvestorsObserver's Sentiment Score for Cyclo Therapeutics Inc click here.
More About Cyclo Therapeutics Inc
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.
Click Here to get the full Stock Report for Cyclo Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter